AzTrials
AzTrials

Cerebral Palsy ChildrenNCT07394985

Fiability of a Telerehabilitation Programme Based on the Neurodevelopmental Treatment (NDT) Model on Gross Motor Function and Functional Performance in Children With Cerebral Palsy.

A study testing neurodevelopmental treatment based on the Bobath concept and neurodevelopmental treatment according to the Bobath concept in people with Cerebral Palsy Children, run by Escola Superior Saúde Fernando Pessoa at 1 site in Portugal.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record

Search all trials

Trial summary

Experimental study with a control group, developed with the aim of analyzing the impact of a telerehabilitation program based on the Neurodevelopmental Treatment (NDT) model on gross motor function and functional performance in children with cerebral palsy. Read more about this study

Who is it for?
Ages 6 months to 6 years
Conditions the study is for
Cerebral Palsy Children
What is being tested?
neurodevelopmental treatment based on the Bobath concept and neurodevelopmental treatment according to the Bobath concept
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 sitePortugal
Study dates
4 Apr 2025to 1 Sep 2026
Phase
Interventional

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 6 years
  • All sexes
  • No healthy volunteers
  • Child

Inclusion criteria Confirmed diagnosis of cerebral palsy; Age between 6 months and 6 years; Ability of the primary caregiver to actively participate in online sessions; Regular access to a device with a camera and internet connection.

Exclusion criteria Orthopaedic surgery or botulinum toxin application in the six months prior to the intervention; Presence of severe comorbidities (cardiorespiratory, cognitive, or sensory) that would limit participation;

Trial locations and contacts

1 site in 1 country.

Portugal1 site
  • Associação do Porto de Paralisia Cerebral

    Porto, Porto District, 4300-008

Other trials in Portugal

About this study

Experimental study with a control group, developed with the aim of analyzing the impact of a telerehabilitation program based on the Neurodevelopmental Treatment (NDT) model on gross motor function and functional performance in children with cerebral palsy.

Read the detailed description

The sample consisted of 20 children divided into two equivalent groups: an experimental group (n = 10), which received the TND intervention program in a synchronous telerehabilitation format for six months, and a control group (n = 10), which maintained the usual care and clinical follow-up plan without additional structured intervention.

The children included had a clinical diagnosis of spastic cerebral palsy, aged between 6 months and 6 years, classified between levels I and IV of the Gross Motor Function Classification System (GMFCS).

The pre-intervention assessment was performed before the start of the program, and the post-intervention assessment took place after six months. The assessments included the GMFM-88, to measure gross motor function, and the CO-OP Performance Measure (COOPM), to assess caregivers' perceptions of performance and satisfaction.

Being tested
neurodevelopmental treatment based on the Bobath concept, neurodevelopmental treatment according to the Bobath concept

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • neurodevelopmental treatment based on the Bobath conceptOther

    Participants in the intervention group receive a structured telerehabilitation program based on neurodevelopmental principles. The intervention is delivered remotely by a physiotherapist through scheduled sessions and focuses on improving motor control, postural alignment, balance, and functional movement according to each child's abilities. The program is individualized and adapted to the functional level of each participant and is conducted over a predefined intervention period.

  • neurodevelopmental treatment according to the Bobath conceptOther

    Participants in the control group continue to receive conventional in-person physiotherapy based on neurodevelopment according to the Bobath concept.

Study groups in NCT07394985
Study groupRoleWhat they receive
Intervention GroupExperimentaltelerhabilitation intervention in accordance with neurodevelopmental treatment
Receives: Other: neurodevelopmental treatment based on the Bobath concept
Control GroupExperimentalface-to-face intervention in accordance with neurodevelopmental treatment
Receives: Other: neurodevelopmental treatment according to the Bobath concept

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Gross Motor Function Measure (GMFM-88)

    instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.

    Measured: Baseline and at the end of the 6-month intervention period

  2. Gross Motor Function Measure (GMFM-88)

    Gross motor function assessed using the Gross Motor Function Measure-88 (GMFM-88), a validated observational instrument designed to evaluate changes in gross motor abilities in children with cerebral palsy.

    Measured: Baseline and at the end of the 6-month intervention period

Secondary outcomes (1)
  1. Canadian Occupational Performance Measure (COPM)

    Occupational performance and satisfaction assessed using the Canadian Occupational Performance Measure (COPM), administered to the child's primary caregiver as a proxy respondent. Caregivers identify meaningful daily activities and rate the child's performance and satisfaction on a 10-point scale. Changes from baseline to post-intervention are analyzed.

    Measured: Baseline and at the end of the 6-month intervention period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2026
  2. Study start4 Apr 2025
  3. Primary completion1 Mar 2026 (estimated)
  4. Study completion1 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
This is a parallel-group experimental study in which participants are assigned to an intervention group or a control group. The intervention group undergoes a structured telerehabilitation program based on neurodevelopmental principles, while the control group continues with usual care. Outcome measures are collected at baseline and post-intervention to assess changes within each group over time.
Masking
Single blind
Who is masked
Care provider
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07394985
Sponsor's protocol ID
ESTUDO_PC_TELEREAB_01
Status last verified
Jan 2026
First submitted
31 Jan 2026
Last updated
6 Feb 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in